Page results
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
New precision therapy for bile duct cancer extends patients’ lives
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
File results
-
FOI/2022/0494 - Treatment of Haemophilia A
-
FOI/2022/0495 - International recruitment
-
FOI/2022/0497 - Departments/ specialties that have functioning air-conditioning
-
FOI/2022/0502 - Asthma treatments
-
FOI/2022/0505 - Type of needles used for insulin administration to patients
-
FOI/2022/0506 - Node positive breast cancer patients undergoing Oncotype testing
-
FOI/2022/0514 - Infant deaths/ stillbirths and cremations
-
FOI/2022/0516 - Number of orthopaedic consultants at Trust
-
FOI/2022/0517 - Mobile phone and data contracts/ spend
-
FOI/2022/0519 - Melanoma treatments